CCDM practice question 3 of 25

Which is the best way to identify sites with high subject attrition?

Full set: 150 questions
Answer options
A: Proportion of patients for which two visit periods have passed without data by site Correct answer
B: Number of late visits per site
C: Proportion of late visits by site
D: Number of patients for which two visit periods have passed without data
Correct Answer:
A. Proportion of patients for which two visit periods have passed without data by site
Explanation

The most effective method to identify sites with high subject attrition is to use a normalized, site-level metric. Option A, the proportion of patients with multiple missed visits by site, is the best choice. Using a proportion (or percentage) normalizes the data, allowing for a fair and accurate comparison between sites with different enrollment numbers. A raw count would be misleading, as a larger site is expected to have more dropouts. The criterion of "two visit periods have passed without data" serves as a standard operational proxy for a subject who is likely lost to follow-up, directly indicating attrition.

Why Incorrect

B. Number of late visits per site: This measures visit delinquency, not subject attrition. A raw number is also a poor metric for comparing sites of different sizes.
C. Proportion of late visits by site: While a proportion is better than a raw number, this metric still measures visit lateness, not subjects permanently leaving the study (attrition).
D. Number of patients for which two visit periods have passed without data: This is a study-level metric, not a site-level one. It provides a total count for the entire study and cannot be used to identify which specific sites are problematic.

References

1. Prokscha, S. (2017). Practical Guide to Clinical Data Management (3rd ed.). CRC Press. In Chapter 13, "Metrics, Reporting, and Study Closeout," the text emphasizes the importance of using rates and proportions for site performance metrics to allow for meaningful comparisons. It discusses tracking subject status, including dropouts, at the site level (pp. 265-267).

2. Society for Clinical Data Management. (2023). Good Clinical Data Management Practices (GCDMP). Section 6.5, "Centralized Monitoring," discusses the use of Key Risk Indicators (KRIs) to monitor site performance. Subject dropout rate per site is a critical KRI used to detect potential issues with site conduct or patient retention.

3. TransCelerate BioPharma Inc. (2020). Risk-Based Quality Management (RBQM) – Key Risk Indicators (KRIs) Library. This industry guidance document lists "Subject Discontinuation Rate" as a core KRI. It is defined as the percentage of subjects who discontinued, calculated per site, to identify sites with abnormally high rates compared to their peers. (Section: KRI Library, KRI ID: SD-01).

Scroll to Top